LIVN Q3 2023 Earnings — LivaNova PLC Revenue & Financial Results | Market Cap Arena

LIVNLivaNova PLC

$3B

Q3 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$286M+13.3% YoY

Gross Profit

$202M70.5% margin

Operating Income

$4M1.6% margin

Net Income

-$7M-2.6% margin

EPS (Diluted)

$-0.14

QoQ Revenue Growth

-2.6%

Cash Flow

Operating Cash Flow

$18M

Free Cash Flow

$9M

Stock-Based Comp.

$12M

Balance Sheet

Total Assets

$2.3B

Total Liabilities

$1.1B

Stockholders' Equity

$1.2B

Cash & Equivalents

$234M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$286M	$253M	+13.3%
Gross Profit	$202M	$171M	+18.1%
Operating Income	$4M	-$132M	+103.4%
Net Income	-$7M	-$107M	+93.2%

Revenue Segments

Cardiopulmonary Segment

$145M51%

Neuromodulation Segment

$129M45%

Advanced Circulatory Support Segment

$11M4%

Geographic Segments

UNITED STATES

$162M56%

Locations Excluding The United States And Europe

$76M27%

Europe

$48M17%